Trial Profile
Comparative pharmacokinetics, pharmacodynamics, efficacy and safety of two asparaginase preparations in children with previously untreated acute lymphoblastic leukemia (ALL).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Sep 2009
Price :
$35
*
At a glance
- Drugs Asparaginase (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Pharmacokinetics
- 16 May 2009 Additional lead trial centre identified as reported by Netherlands Trial Register.
- 16 May 2009 New source identified and integrated (Netherlands Trial Register, record no. NTR402).
- 06 Mar 2009 Status changed from not stated to completed.